Home›Clinical trials›District of Columbia

GLP-1 clinical trials in District of Columbia: 1 recruiting now

By John Samaras, EditorRegistry checked September 4, 2026

One GLP-1 clinical trial is recruiting at one site in one city across District of Columbia. Every site below is listed with its city and, where the sponsor publishes one, the number to call.

Every study recruiting in District of Columbia

  1. Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV

    Phase 2. Run by University of Maryland, Baltimore. Registry number NCT06691243.

    A study of a GLP-1 medicine, semaglutide, in people with cocaine use disorder.

    Who can join. Adults 18 to 65, have cocaine use disorder, BMI 20+.

    1 site in District of Columbia

    • Institute of Human Virology at the University of Maryland School of Medicine, Washington D.C.. 240-667-6202

Source: ClinicalTrials.gov, the federal registry, read September 4, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Screening for a study can take weeks. If you need the drug now, Strut Health is the cheapest cash route on the chart, from $149 a month. That price buys compounded semaglutide, a pharmacy-made version that is not FDA-approved and is not Wegovy, Ozempic, Zepbound or Mounjaro.

Visit Strut Health ↗

Clinical trials by state

Every state with a GLP-1 study recruiting today. 48 of them.

John Samaras, editor of GLP Chart
John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this siteLinkedInContact
Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.